Abstract
Question
I frequently encounter infants with symptoms suggestive of allergy after being introduced to standard cow’s milk formula. Parents are concerned and ask for recommendations regarding formula alternatives. Which formulas are best for children with cow’s milk allergy?
Answer
Cow’s milk allergy is common, and the criterion standard for diagnosis is elimination, provocation (with a double-blind, placebo-controlled food challenge protocol), and re-elimination. The allergy is treated by eliminating cow’s milk protein from the diet. Formula alternatives include hydrolyzed cow’s milk formula, rice-based formula, soy-based formula, and amino acid–based formula, which are all nutritionally adequate alternatives to cow’s milk formula. Symptom severity, patient preference, cost, and efficacy are factors to be considered when choosing an alternative.
Exclusive breastfeeding has been recommended by the World Health Organization to be the sole form of nutrition for infants in the first 6 months of life.1 However, many women might supplement or replace breastfeeding with infant formula for reasons including difficulties with breastfeeding and concern for maternal and child health.2 The most commonly used and recommended infant formula has cow’s milk as a source of protein. However, infants who are introduced to these formulas develop cow’s milk allergy (CMA) more frequently compared to exclusively breastfed infants.3
Cow’s milk allergy
Cow’s milk allergy is one of the most common food allergies in infants,4,5 with a 14% to 17% reporting rate by parents, and a much lower reporting rate by health care professionals.3,6 A review of 229 papers on CMA from 1967 to 2001 reported a CMA incidence of 2% to 3% in the first year of life.5 This is similar to the 2.7% reported by the World Allergy Organization (WAO) following a review of 5 studies of CMA in northern Europe.7 The discrepancy between parental reporting and clinically confirmed CMA rates might be because of parental misattribution of common symptoms of infancy (ie, regurgitation, colic, eczema) to CMA.6
The main allergens in cow’s milk are whey proteins (α-lactalbumin, β-lactoglobulin, bovine serum albumin, and bovine immunoglobulins) and casein proteins (α-s1, α-s2, β-casein, κ-casein).7 Immunoglobulin E (IgE)–mediated reactions present within 2 hours of exposure and manifest with cutaneous, gastrointestinal, and respiratory symptoms.6,7 Non–IgE-mediated reactions are less common and present as delayed reactions, typically involving gastrointestinal symptoms.6 Other symptoms might include food-protein–induced enterocolitis syndrome, bloody stool relating to allergic proctocolitis, or chronic gastrointestinal symptoms such as diarrhea and failure to thrive.6 Anaphylaxis is rare but does occur in 0.8% to 9% of infants with CMA.7
Diagnosing CMA
Varying presentations, CMA symptoms that overlap with normal symptoms of infancy, and a lack of validated diagnostic tests lead to misdiagnosis of CMA.6 Knowing the milk or dairy content of all ingested food and beverages, symptom presentation, results of cutaneous skin prick tests and atopy patch tests, and food-specific serum IgE levels can help with diagnosis.6 The criterion standard for CMA diagnosis is the oral food challenge test, which involves elimination; provocation using double-blind, placebo-controlled food challenge protocol; and re-elimination.7,8 However, if objective CMA symptoms are present in young children, results of the open-food challenge can be considered sufficient evidence for CMA diagnosis.7
Treating with elimination
Treating using elimination of cow’s milk from the diet4 results in remission in 85% of infants.5,7 In exclusively breastfed infants, this involves elimination of all milk products from the mother’s diet.4,6,7 In infants younger than 2 years old who are fed any amount of formula, this necessitates a substitute formula.7 Substitutes include hydrolyzed cow’s milk protein, hydrolyzed rice or soy protein, and amino acid–based formula. Factors that must be considered are formula efficacy, adequate nutrient intake, family preferences, and cost.4,9
Hydrolyzed cow’s milk formula
Partially hydrolyzed cow’s milk formula should not be used to treat CMA, as cross-reactivity has been demonstrated in roughly 50% of infants with CMA.7,8 However, an extensively hydrolyzed formula that contains no peptides with a molecular weight greater than 5000 Da is hypoallergenic10; according to the American Academy of Pediatrics and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), more than 90% of children with CMA will tolerate it.8,10 In an open randomized controlled trial of 92 infants with known CMA, extensively hydrolyzed formula was well tolerated and nutritionally adequate for infant growth.11 Among 170 infants younger than 2 years of age with confirmed CMA, only 2.2% had a reaction to extensively hydrolyzed formula compared to 10% using soy-based formula.12 Formula type is essential to consider in cases of severe allergy.4,8,9 Nevertheless, bitter taste,11,13-15 cost,9 and risk of anaphylaxis8 are challenges to using extensively hydrolyzed cow’s milk formula.
Hydrolyzed rice formula
Hydrolyzed rice formulas have been used in Europe for decades but are not universally available.13 A recent review of 11 clinical trials using hydrolyzed rice formula in infants with CMA reported no cross-reactivity. Seven studies found satisfactory growth patterns in healthy children and catch-up growth in children with CMA.14 A multicentre study of 100 infants with confirmed CMA used a skin prick test to detect rice-specific IgE level in 4% of infants; there were no associated symptoms.9 Western blotting results were negative in ricesensitized children, indicating hydrolysis of rice protein in formula modifies its allergenic properties and prevents an immune response.9 Limitations of hydrolyzed rice formula include accessibility to formula13 and bitter taste that might reduce adherence.14 Partially hydrolyzed rice formulas are equally as efficacious in CMA treatment and taste scores match those of soy formulas.15
Soy-based formula
Using soy-based formula in the treatment of CMA in infants has long been an area of controversy. Soy formulas have been shown to promote appropriate infant growth patterns, but some studies suggest lower weight gain in infants fed soy formula compared to cow’s milk formula.16 A randomized controlled trial of 170 infants with confirmed CMA reported allergic responses in 10% of infants fed soy formula.12 Adverse reactions to soy were similar in IgE-mediated and non-IgE–mediated CMA, and reactions were more common in infants younger than 6 months of age.7,12,17 A randomized-order, double-blind test of 50 adult participants (mean age of 34.4 years) comparing 12 different milk alternatives for infants with CMA based on taste, texture, and smell found soy formula to have the highest overall scores, followed by soy and rice hydrolysates.15 Soy-based formulas are also more affordable than extensively hydrolyzed formulas.17 Soy-based formula limitations are the unknown effects of phytate and phytoestrogens found in soy13,16 and cross-reactivity with CMA, especially in younger infants.4,8,12
Amino acid–based formula
Amino acid–based formulas are composed of elemental amino acids. They are hypoallergenic—as defined by the American Academy of Pediatrics—and are indicated in cases where infants are unable to tolerate extensively hydrolyzed hypoallergenic formulas (eg, cow’s milk or soy milk),4,7,14 or in infants who have anaphylactic reactions to cow’s milk protein.7 Use of amino acid–based formula demonstrated nutritional adequacy in growth patterns of infants with CMA (tolerance of 100%).4 The main drawbacks are increased cost (6 to 8 times more expensive than extensively hydrolyzed formula)13 and poor palatability because of the elemental form, resulting in refusal by some infants.9
Selecting formula alternatives
Symptom severity, patient preference, cost, and efficacy should be considered when selecting a formula alternative, as all options are nutritionally adequate alternatives to cow’s milk formula.4,6-9
Soy formula, although reported to cause reaction in 10% to 14% of infants with CMA,8,12 is more palatable and more affordable than extensively hydrolyzed formula.13,15 Guidelines from the ESPGHAN and the WAO recommend against soy formula in infants younger than 6 months of age with CMA because of cross-reactivity,7,10 but soy formula might be recommended for IgE-mediated CMA after 6 months of age.4,10,12,16 Hydrolyzed soy formula was also found to be hypoallergenic and should be considered.7
Extensively hydrolyzed cow’s milk formula is recommended as first-line treatment for CMA in infants by the ESPGHAN and the WAO.7,10 A prospective, open randomized controlled trial in Spain comparing extensively hydrolyzed formula and hydrolyzed rice formula in 92 infants diagnosed with IgE-mediated CMA reported that growth curves followed normal patterns with both options, and hydrolyzed rice formula was well tolerated by all infants with moderate to severe CMA, while extensively hydrolyzed formula induced an allergic response in 1 child.11 Rice-based formula is more palatable and more affordable when compared to extensively hydrolyzed formula,11 and is recommended as first-line treatment in infant CMA when available, even in severe clinical cases.9,13,14
In treating children with allergy to cow’s milk and soy formula, hydrolyzed rice formula and extensively hydrolyzed formula should be considered. A study of 18 children (median age of 5 years) with CMA who were treated with soy-based formula but subsequently developed reactions after 2 to 18 months of treatment evaluated the efficacy of hydrolyzed rice formula as an option for infants with CMA and soy allergy.18 Results of a skin prick test showed reactions to rice in 8 children and to rice hydrolysate in 2 children, and serology results found antibodies to rice in 7 children. However, results of double-blind, placebo-controlled food challenge tests with hydrolyzed rice formula were found to be negative in all cases, supporting the notion of rice-based formula as an alternative to amino acid–based formula in treating infants with CMA and soy allergy.18 In infants with an allergic reaction or an anaphylactic reaction to extensively hydrolyzed formula, amino acid–based formula is indicated.4,7,14 If symptoms do not improve with amino acid–based formula, the diagnosis is likely not CMA.3
Alternative mammalian milk formulas are not indicated in infants with CMA because of cross-reactivity.3,7
Child Halth Update is produced by the Pediatric Research in Emergency Therapeutics (PRETx) program (www.pretx.org) at the BC Children’s Hospital in Vancouver, BC. Ms Kipfer is a member and Dr Goldman is Director of the PRETx program. The mission of the PRETx program is to promote child health through evidence-based research in therapeutics in pediatric emergency medicine.
Do you have questions about the effects of drugs, chemicals, radiation, or infections in children? We invite you to submit them to the PRETx program by fax at 604 875-2414; they will be addressed in future Child Health Updates. Published Child Health Updates are available on the Canadian Family Physician website (www.cfp.ca).
Footnotes
Competing interests
None declared
This article is eligible for Mainpro+ certified Self-Learning credits. To earn credits, go to www.cfp.ca and click on the Mainpro+ link.
La traduction en français de cet article se trouve à www.cfp.ca dans la table des matières du numéro de mars 2021 à la page e79.
References
- 1.World Health Organization . Breastfeeding: recommendations. Geneva, Switz: World Health Organization; 2021. Available from: https://www.who.int/health-topics/breastfeeding#tab=tab_2. Accessed 2021 Feb 4. [Google Scholar]
- 2.Odom EC, Li R, Scanlon KS, Perrine CG, Grummer-Strawn L.. Reasons for earlier than desired cessation of breastfeeding. Pediatrics 2013;131(3):e726-32. Epub 2013 Feb 18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Vandenplas Y. Prevention and management of cow’s milk allergy in non-exclusively breastfed infants. Nutrients 2017;9(7):731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dupont C, Chouraqui JP, Linglart A, Bocquet A, Darmaun D, Feillet F, et al. Nutritional management of cow’s milk allergy in children: an update. Arch Pediatr 2018;25(3):236-43. Epub 2018 Mar 22. [DOI] [PubMed] [Google Scholar]
- 5.Høst A. Frequency of cow’s milk allergy in childhood. Ann Allergy Asthma Immunol 2002;89(6 Suppl 1):33-7. [DOI] [PubMed] [Google Scholar]
- 6.Munblit D, Perkin MR, Palmer DJ, Allen KJ, Boyle RJ.. Assessment of evidence about common infant symptoms and cow’s milk allergy. JAMA Pediatr 2020;174(6):599-608. [DOI] [PubMed] [Google Scholar]
- 7.Fiocchi A, Brozek J, Schünemann H, Bahna SL, von Berg A, Beyer K, et al. World Allergy Organization (WAO) diagnosis and rationale for action against cow’s milk allergy (DRACMA) guidelines. World Allergy Organ J 2010;3(4):57-161. Epub 2010 Apr 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zeiger RS. Dietary aspects of food allergy prevention in infants and children. J Pediatr Gastroenterol Nutr 2000;30 Suppl:S77-86. [DOI] [PubMed] [Google Scholar]
- 9.Fiocchi A, Restani P, Bernardini R, Lucarelli S, Lombardi G, Magazzù G, et al. A hydrolysed rice-based formula is tolerated by children with cow’s milk allergy: a multi-centre study. Clin Exp Allergy 2006;36(3):311-6. [DOI] [PubMed] [Google Scholar]
- 10.Koletzko S, Niggemann B, Arato A, Dias JA, Heuschkel R, Husby S, et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESP-GHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr 2012;55(2):221-9. [DOI] [PubMed] [Google Scholar]
- 11.Reche M, Pascual C, Fiandor A, Polanco I, Rivero-Urgell M, Chifre R, et al. The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow’s milk protein allergy. Pediatr Allergy Immunol 2010;21(4 Pt 1):577-85. Epub 2010 Mar 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Klemola T, Vanto T, Juntunen-Backman K, Kalimo K, Korpela R, Varjonen E.. Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow’s milk allergy: a prospective, randomized study with a follow-up to the age of 2 years. J Pediatr 2002;140(2):219-24. [DOI] [PubMed] [Google Scholar]
- 13.Fiocchi A, Dahda L, Dupont C, Campoy C, Fierro V, Nieto A.. Cow’s milk allergy: towards an update of DRACMA guidelines. World Allergy Organ J 2016;9(1):35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bocquet A, Dupont C, Chouraqui JP, Darmaun D, Feillet F, Frelut ML, et al. Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow’s milk protein allergy. Arch Pediatr 2019;26(4):238-46. Epub 2019 Apr 9. [DOI] [PubMed] [Google Scholar]
- 15.Pedrosa M, Pascual CY, Larco JI, Esteban MM.. Palatability of hydrolysates and other substitution formulas for cow’s milk-allergic children: a comparative study of taste, smell, and texture evaluated by healthy volunteers. J Investig Allergol Clin Immunol 2006;16(6):351-6. [PubMed] [Google Scholar]
- 16.ESPGHAN Committee on Nutrition; Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, et al. Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2006;42(4):352-61. [DOI] [PubMed] [Google Scholar]
- 17.Vandenplas Y, Koletzko S, Isolauri E, Hill D, Oranje AP, Brueton M.. Guidelines for the diagnosis and management of cow’s milk protein allergy in infants. Arch Dis Child 2007;92(10):902-8. Errata in: Arch Dis Child 2007 Oct;92(10):following 908, Arch Dis Child 2008 Jan;93(1):93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fiocchi A, Travaini M, D’Auria E, Banderali G, Bernardo L, Riva E.. Tolerance to a rice hydrolysate formula in children allergic to cow’s milk and soy. Clin Exp Allergy 2003;33(11):1576-80. [DOI] [PubMed] [Google Scholar]